pteridines has been researched along with Carcinoma, Ovarian Epithelial in 1 studies
Carcinoma, Ovarian Epithelial: A malignant neoplasm that originates in cells on the surface EPITHELIUM of the ovary and is the most common form of ovarian cancer. There are five histologic subtypes: papillary serous, endometrioid, mucinous, clear cell, and transitional cell. Mutations in BRCA1, OPCML, PRKN, PIK3CA, AKT1, CTNNB1, RRAS2, and CDH1 genes are associated with this cancer.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pautier, P | 1 |
| Motte-Rouge, T | 1 |
| Lécuru, F | 1 |
| Classe, JM | 1 |
| Ferron, G | 1 |
| Floquet, A | 1 |
| Kurtz, JE | 1 |
| Freyer, G | 1 |
| Hardy-Bessard, AC | 1 |
1 review available for pteridines and Carcinoma, Ovarian Epithelial
| Article | Year |
|---|---|
Prise en charge médicale de la récidive du cancer épithélial de l'ovaire: Medical management of recurrent epithelial ovarian cancer.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Che | 2021 |